SOURCE-LINKED STUDY SUMMARY
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.
PED EVIDENCE INTERPRETATION
What did the classic testosterone muscle trial establish?
High-dose testosterone increased muscle size and strength, including without training. Testosterone plus training increased fat-free mass by 6.1 kg. That is not a measurement of 6.1 kg of pure contractile muscle. [1]
- Design
- Four randomized groups; 43 healthy men
- Exposure
- Testosterone enanthate 600 mg weekly or placebo
- Training comparison
- With or without standardized lifting three times weekly
- Duration
- 10 weeks
The evidence at a glance
| Change at 10 weeks | Testosterone, no exercise | Placebo, no exercise | Uncertainty / meaning |
|---|---|---|---|
| Triceps area, MRI [1] | +424 ± 104 mm² | −81 ± 109 mm² | P < .05 |
| Quadriceps area, MRI [1] | +607 ± 123 mm² | −131 ± 111 mm² | P < .05 |
| Bench-press strength [1] | +9 ± 4 kg | −1 ± 1 kg | P < .05 |
| Squatting capacity [1] | +16 ± 4 kg | +3 ± 1 kg | P < .05 |
OUR READING OF THE EVIDENCE
What this changes
The MRI and strength outcomes strengthen the anabolic interpretation beyond a change in body composition alone. [1]
What it does not establish
The trial does not estimate ordinary TRT results, retained gains after stopping, or long-term safety. Its combination-group gain is a within-group change, not the treatment difference versus placebo. [1]
Put it in context
The 2001 dose-response experiment adds a different test
With endogenous testosterone suppressed, graded testosterone doses over 20 weeks produced dose-related changes in fat-free mass, muscle size and strength. Hemoglobin and HDL cholesterol also changed. More anabolic effect therefore cannot be treated as evidence of a better benefit–risk balance. [2]
Read the related study summaryReplacement therapy does not reproduce this experiment
The Testosterone Trials studied older symptomatic men with low testosterone. Benefits varied by outcome, with null primary vitality and walking results in their respective trials. Differences in population, exposure and endpoint prevent direct extrapolation from the 600 mg experiment. [3]
Read the related study summarySources and transparency
Funding and complete adverse-event tables were not verified from the 1996 full text. The abstract is insufficient for a comprehensive safety appraisal. [1]
Original compact summary and study details
- What was studied
- Randomized trial comparing weekly testosterone enanthate or placebo, each with or without standardized resistance training.
- Who / model studied
- Forty-three normal men received 600 mg testosterone enanthate or placebo weekly for 10 weeks; exercise groups lifted three times weekly.
- Studied dose & schedule
- In this 10-week randomized study of 43 men, the testosterone groups received injections of 600 mg testosterone enanthate once weekly; comparator groups received placebo injections. Exercise groups also performed standardized weight-lifting three times weekly. This describes the study intervention, not a recommended regimen.
- What the study found
- Testosterone plus exercise increased fat-free mass by 6.1 kg; bench-press strength rose 22 kg and squat capacity 38 kg. Testosterone without exercise also outperformed placebo for measured muscle size and strength. Mood and behavior were unchanged.
- Limitations & context
- This was a small, 10-week study in normal men using a supraphysiologic regimen. The abstract reports mood and behavior but no longer-term safety assessment or author-stated limitations.
Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1056/nejm199607043350101